News – Page 348
-
Business
Takeda to consolidate vaccines business in Boston
Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts
-
News
Call to embed science in US foreign policy
National Research Council tells US to take science and technology more seriously on the diplomatic stage
-
NewsBiosafety blunder as US sends live anthrax to labs around world
Key government committee demands answers after Department of Defense inadvertently sends out live pathogen
-
NewsChemistry Nobel laureate Irwin Rose dies aged 88
Biochemist revealed protein pathway for cell breakdown
-
NewsPostdocs struggle with poor job security and stress in Europe
Career study finds flexibility of temporary contracts delivers poor returns for both employer and employee
-
NewsNIH-funded principal investigators fell sharply in 2010
New analysis finds PIs funded by US National Institutes of Health grew steadily from 1985 to around 2010, but has since dropped steeply
-
Research
Simple sensor can spot cancer markers in minutes
Test can rapidly detect mutant tumour nucleic acids in boost for personalised medicine
-
Business
OM Group to be sold and split
Apollo Global Management will buy the firm for $1bn, then sell electronic materials business to Platform Specialty Products
-
NewsScientists hail partial victory on efforts to block cuts to European research programme
Provisional compromise between EU politicians sees Horizon 2020 cut by €500m less than originally announced
-
News
Chemical regulation reform gains momentum in both chambers of US Congress
Bipartisan bill to revamp outdated legislation is advancing in the Senate and the House, but the window to enact reform could be narrow
-
Business
Teva fined $1.2bn in pay-for-delay case
Company illegally blocked generic competition of sleep disorder drug, and settlement terms tighten up rules on anticompetitive behaviour
-
News
Majority of global chemical weapons stockpiles destroyed
End to chemical weapons in sight as 90% of world’s declared stockpiles dismantled
-
NewsUK launches universal ban on legal highs
The government will make it illegal to sell any psychoactive substance in a bid to crack down on designer drugs
-
ResearchNoble gas joins σ-hole interaction crowd
Surprising ‘aerogen bonding’ completes set of p-block groups exhibiting the phenomenon
-
Business
Achillion partners with Janssen to boost hepatitis C pipeline
Development deal worth up to $1.1bn includes three investigational drugs aiming to extend treatment options in fast-moving market
-
ResearchGecko-inspired adhesives for microfluidics
Technical innovation in reversible bonding allows for strong and affordable devices
-
ResearchPurely inorganic aromatic ion synthesised
Aromatic anion made from nitrogen and phosphorus synthesised
-
NewsFallout from rogue US drug lab chemist could lead to thousands of retrials
Ruling by Massachusetts court means defendants in drug cases can pursue retrials without fear of harsher sentences
-
Business
Actavis plan to thwart generics blocked
Company prevented from withdrawing original formulation of Alzheimer’s drug to force patients onto extended release version and extend patent exclusivity
-
ResearchTouch lights up supercooled material
Weight of a single cell is enough to induce crystallisation in amorphous organic material